[go: up one dir, main page]

JPS5338617A - Preparation of hepatitis-b vaccine - Google Patents

Preparation of hepatitis-b vaccine

Info

Publication number
JPS5338617A
JPS5338617A JP11273376A JP11273376A JPS5338617A JP S5338617 A JPS5338617 A JP S5338617A JP 11273376 A JP11273376 A JP 11273376A JP 11273376 A JP11273376 A JP 11273376A JP S5338617 A JPS5338617 A JP S5338617A
Authority
JP
Japan
Prior art keywords
vaccine
hepatitis
preparation
treatkng
infectivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11273376A
Other languages
Japanese (ja)
Other versions
JPS5840930B2 (en
Inventor
Satoru Funakoshi
Yatsuhiro Kamimura
Tsunekazu Fukushima
Toshihiko Tanaka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
GC Biopharma Corp
Original Assignee
Green Cross Corp Japan
Green Cross Corp Korea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Green Cross Corp Japan, Green Cross Corp Korea filed Critical Green Cross Corp Japan
Priority to JP11273376A priority Critical patent/JPS5840930B2/en
Publication of JPS5338617A publication Critical patent/JPS5338617A/en
Publication of JPS5840930B2 publication Critical patent/JPS5840930B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PURPOSE: To prepare high purity hepatitis-B vaccine having high antigenicity and free of infectivity, by heat-treatkng human blood-plasma containing hepatitisB virus, and purifying by the ammonium sulfate fractionation and gel filtration.
COPYRIGHT: (C)1978,JPO&Japio
JP11273376A 1976-09-20 1976-09-20 Manufacturing method for hepatitis B vaccine Expired JPS5840930B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP11273376A JPS5840930B2 (en) 1976-09-20 1976-09-20 Manufacturing method for hepatitis B vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11273376A JPS5840930B2 (en) 1976-09-20 1976-09-20 Manufacturing method for hepatitis B vaccine

Publications (2)

Publication Number Publication Date
JPS5338617A true JPS5338617A (en) 1978-04-08
JPS5840930B2 JPS5840930B2 (en) 1983-09-08

Family

ID=14594172

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11273376A Expired JPS5840930B2 (en) 1976-09-20 1976-09-20 Manufacturing method for hepatitis B vaccine

Country Status (1)

Country Link
JP (1) JPS5840930B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59101426A (en) * 1982-11-29 1984-06-12 Green Cross Corp:The Method for producing vaccine for preventing hepatitis B infection
JPS6136228A (en) * 1984-07-09 1986-02-20 ジエネンテク，インコーポレイテツド Purification of hepatitis surface antigen and product
US7038016B2 (en) * 2001-08-21 2006-05-02 Apex Bioscience, Inc. Methods for purification of an activated PEG solution and for the synthesis of a modified hemoglobin solution

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59101426A (en) * 1982-11-29 1984-06-12 Green Cross Corp:The Method for producing vaccine for preventing hepatitis B infection
US4565697A (en) * 1982-11-29 1986-01-21 Green Cross Corporation Process for producing a hepatitis B infection preventing vaccine
JPS6136228A (en) * 1984-07-09 1986-02-20 ジエネンテク，インコーポレイテツド Purification of hepatitis surface antigen and product
US7038016B2 (en) * 2001-08-21 2006-05-02 Apex Bioscience, Inc. Methods for purification of an activated PEG solution and for the synthesis of a modified hemoglobin solution

Also Published As

Publication number Publication date
JPS5840930B2 (en) 1983-09-08

Similar Documents

Publication Publication Date Title
IL58759A0 (en) Purified proteins,their preparation and pharmaceutical compositions containing them
JPS52114018A (en) Purification and isolation of hepatisis virus for producing vaccine
DE2960747D1 (en) Process for the preparation of cyclic dimethylpolysiloxanes
JPS53107479A (en) Preparation of human lysozyme
JPS5338617A (en) Preparation of hepatitis-b vaccine
JPS5396388A (en) Preparation of l-phenylalanine
JPS53123547A (en) Moisture absorption element
DE2964881D1 (en) Parainfluenza virus vaccine and its preparation
JPS5352622A (en) Composition for preparation of bordeaux mixture
NO791572L (en) PROCEDURE FOR THE PREPARATION OF 1,5-DIMETHYL-BICYCLO (3,2,1) OCTANOL-8
JPS5257293A (en) Preparation of novel copolymers
JPS5436255A (en) Novel sesquiterpene analogue, its preparation, and pharmatheutical containing the same
JPS5419908A (en) Preparation and use of cis-5-undecen-2-one and its novel intermediate
JPS5359095A (en) Preparation of 7-aminocephem cpds.
JPS53127808A (en) Preparation of human albumin
JPS535124A (en) Organoxilicon composition
JPS5420195A (en) Preparation of guanosine-5'-monophosphoric acid
DK27179A (en) PROCEDURE FOR THE PREPARATION OF ALKYLED CYCLIC AMIDES
JPS52118661A (en) Preparation of heat pipe
DK148709C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF N ', N'-DISUBSTITUTED N-AMINO-ALKANOYL-4,6-DIMETHYL-O-ANISIDINE OR NON-TOXIC ACID ADDITION SALTS
JPS5312491A (en) Preparation of l-alginine by fermentation
JPS52156879A (en) Preparation of piperazine derivatives
JPS52156920A (en) Proauction of raw influenza virus vaccine
JPS5283411A (en) Preparation of 3,3-dimethyl-4-pentenoic acid and its derivatives
JPS5341478A (en) Preparation of yeast cells